
PURE Bioscience Q1 FY2026 Financial Results
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results Company Overview PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company,” “we,” or “our”) is the creator of a patented, non-toxic antimicrobial based on silver dihydrogen citrate (SDC). The Company develops and…












